Literature DB >> 16941487

Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice.

D Z Christensen1, M V Olesen, H Kristiansen, J D Mikkelsen, D P D Woldbye.   

Abstract

Although electroconvulsive seizures (ECS) are widely used as a treatment for severe depression, the working mechanism of ECS remains unclear. Repeated ECS causes anticonvulsant effects that have been proposed to underlie the therapeutic effect of ECS, and neuropeptide Y (NPY) is a potential candidate for mediating this anticonvulsant effect. Repeated ECS results in prominent increases in NPY synthesis. In contrast, NPY-sensitive receptor binding is decreased, so it is unclear whether ECS causes a net increase in NPY signalling. Agonist-stimulated [35S]GTPgammaS binding is a method for detecting functional activation of G-protein-coupled receptors. The present study in mice examined the effects of daily ECS for 14 days on NPY-stimulated [35S]GTPgammaS functional binding and compared this with gene expression of NPY and NPY receptors as well as [125I]peptide YY (PYY) binding in hippocampus of the same animals. Significant increases in NPY mRNA and concomitant reductions in NPY-sensitive binding were found in the dentate gyrus, hippocampal CA1, and neocortex of ECS treated mice, which is consistent with previous rat data. These changes remained significant 1 week after repeated ECS. Significant increases in NPY Y1, Y2, and Y5 mRNA were found in the dentate gyrus after ECS. Surprisingly, unaltered levels of functional NPY receptor binding accompanied the decreased NPY-sensitive binding. This suggests that mechanisms coupling NPY receptor stimulation to G-protein activation could be augmented after repeated ECS. Thus increased synthesis of NPY after repeated ECS should result in a net increase in NPY signalling in spite of reduced levels of NPY-sensitive binding. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941487     DOI: 10.1002/jnr.21028

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  3 in total

1.  Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro.

Authors:  João Martins; Filipe Elvas; Dan Brudzewsky; Tânia Martins; Bogdan Kolomiets; Pedro Tralhão; Casper R Gøtzsche; Cláudia Cavadas; Miguel Castelo-Branco; David P D Woldbye; Serge Picaud; Ana R Santiago; António F Ambrósio
Journal:  ASN Neuro       Date:  2015-08-26       Impact factor: 4.146

2.  Gene Therapy Vector Encoding Neuropeptide Y and Its Receptor Y2 for Future Treatment of Epilepsy: Preclinical Data in Rats.

Authors:  Julia Alicja Szczygieł; Kira Iben Danielsen; Esbjörn Melin; Søren Hofman Rosenkranz; Stanislava Pankratova; Annika Ericsson; Karin Agerman; Merab Kokaia; David Paul Drucker Woldbye
Journal:  Front Mol Neurosci       Date:  2020-12-04       Impact factor: 5.639

3.  Anxiolytic-Like Effects of Increased Ghrelin Receptor Signaling in the Amygdala.

Authors:  Morten Jensen; Cecilia Ratner; Olga Rudenko; Søren H Christiansen; Louise J Skov; Cecilie Hundahl; David P D Woldbye; Birgitte Holst
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-29       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.